A bibliometric analysis of the 100 most-influential papers in the field of anti-diabetic drugs

Author:

Azam Fatima1ORCID,Dawood Muhammad Hamza2ORCID,Roshan Aroosa1ORCID,Urooj Maryam1ORCID,Khan Zoha1ORCID,Larik Muhammad Omar1ORCID,Lakdawala Fatima Mustafa3ORCID,Moulvi Ahad Yousuf3ORCID,Salim Ifrah3ORCID,Zaidi Mehak Abbas3ORCID,Imran Alizeh3ORCID

Affiliation:

1. Dow International Medical College, Dow University of Health Sciences, Karachi, Sindh, 74200, Pakistan

2. United Medical & Dental College, Karachi, Sindh, 75190, Pakistan

3. Ziauddin Medical College, Karachi, Sindh, 75000, Pakistan

Abstract

Aim: We analyzed the 100 most-cited articles on all anti-diabetic drugs. A comprehensive literature review found no bibliometrics on this. Methods: Two researchers independently extracted articles from Scopus and ranked them by citation count as the ‘top 100 most-cited’. Results: The median number of citations is 1385.5. Most articles are from the USA (n = 59). Insulin has the most papers (n = 24). Majority (n = 76) were privately funded and contained at least one conflict of interest (n = 66). The New England Journal of Medicine has the most publications (n = 44). Male authors made majority of both first and last authorship positions. Conclusion: This study aims to aid in directing future research and in reducing biases.

Publisher

Informa UK Limited

Subject

Biotechnology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3